2 Sun Pharma US Units To Pay $85M In Generic Drugs MDL
Two U.S. subsidiaries of Indian drugmaker Sun Pharma have agreed to shell out a combined $85 million to a proposed class of direct purchaser plaintiffs in sweeping multidistrict litigation over alleged...To view the full article, register now.
Already a subscriber? Click here to view full article